PROFILPELAJAR.COM

Lorediplon
Clinical data
ATC code	None;
Legal status
Legal status	In general: non-regulated;
Identifiers
	IUPAC name N-{2-fluoro-5-[3-(thiophen-2-ylcarbonyl)pyrazolo[1,5-a]pyrimidin-7-yl]phenyl}-N-methylacetamide;
CAS Number	917393-39-6 ;
PubChem CID	12004146;
ChemSpider	10176613 ;
UNII	VKU6Z23NSY;
ChEMBL	ChEMBL4303403;
CompTox Dashboard (EPA)	DTXSID00238684 ;
Chemical and physical data
Formula	C20H15FN4O2S
Molar mass	394.42 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C(c2cnn3c(c1ccc(F)c(N(C(=O)C)C)c1)ccnc23)c4sccc4;
	InChI InChI=1S/C20H15FN4O2S/c1-12(26)24(2)17-10-13(5-6-15(17)21)16-7-8-22-20-14(11-23-25(16)20)19(27)18-4-3-9-28-18/h3-11H,1-2H3 ; Key:NQPOCLFSADOXBR-UHFFFAOYSA-N ;
	(verify)

Lorediplon (INN) is a nonbenzodiazepine of the pyrazolopyrimidine family that is being pursued as a treatment for insomnia but has not completed development.^[1]^[2]

References

^ World Health Organization (2011). "International Nonproprietary Names for Pharmaceutical Substances (INN): Proposed INN: List 105" (PDF). WHO Drug Information. 25 (2): 179.
^ Misra AK, Sharma PK (2020). "Sedative and Hypnotic Drugs". In Uddin MS, Rashid M (eds.). Advances in Neuropharmacology: Drugs and Therapeutics. New York: Apple Academic Press. p. 441. ISBN 978-0-429-51589-7.

This sedative-related article is a stub. You can help Wikipedia by expanding it.